Glutaral

Glutaral

SCHEMBL1150556

O=CCCCC=O.[PbH2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutaral SCHEMBL836 0.95 — —
Glutaral SCHEMBL1285455 0.95 HIF1A (1.00) —
Glutaral SCHEMBL7198821 0.91 — —
Glutaral SCHEMBL1842399 0.91 — —
Glutaral SCHEMBL22799073 0.91 — —
Glutaral SCHEMBL23631391 0.91 — —
Glutaral SCHEMBL11499681 0.91 — —
Glutaral SCHEMBL6449134 0.91 — —
Glutaral SCHEMBL2594901 0.91 — —
Glutaral SCHEMBL845792 0.91 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114845741-A Contrast agents for 3D ex vivo imaging of blood vessels and tubular structures in the kidney 苏黎世大学 2022-08-02 — — CN disclosed
US-20160263279-A1 BIOLOGIC REPLACEMENT FOR FIBRIN CLOT CHILDREN'S MEDICAL CENTER CORPORATION (US) 2016-09-15 — — US disclosed
US-20140134249-A1 BIOLOGIC REPLACEMENT FOR FIBRIN CLOT CHILDREN'S MEDICAL CENTER CORPORATION (US) 2014-05-15 — — US disclosed
US-8642735-B2 Biologic replacement for fibrin clot CHILDREN'S MEDICAL CENTER CORPORATION (US) 2014-02-04 — — US disclosed
US-20120201896-A1 BIOLOGIC REPLACEMENT FOR FIBRIN CLOT CHILDREN'S MEDICAL CENTER CORPORATION (US) 2012-08-09 — — US disclosed
US-20110306555-A1 BIOLOGIC REPLACEMENT FOR FIBRIN CLOT CHILDREN'S MEDICAL CENTER CORPORATION (US) 2011-12-15 — — US disclosed
US-20110027338-A1 BIOLOGIC REPLACEMENT FOR FIBRIN CLOT CHILDREN'S MEDICAL CENTER CORPORATION (US) 2011-02-03 — — US disclosed
US-7838630-B2 Biologic replacement for fibrin clot CHILDREN'S MEDICAL CENTER CORPORATION (US) 2010-11-23 — — US disclosed
US-20080031923-A1 Biologic Replacement for Fibrin Clot THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2008-02-07 — — US disclosed
EP-1610754-A2 BIOLOGIC REPLACEMENT FOR FIBRIN CLOT THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2006-01-04 — — EP disclosed
US-20040059416-A1 Biologic replacement for fibrin clot NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2004-03-25 — — US disclosed
WO-2003011107-A2 BIOLOGIC REPLACEMENT FOR FIBRIN CLOT THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2003-02-13 — — WO disclosed
US-20020123805-A1 Biologic replacement for fibrin clot CHILDREN'S MEDICAL CENTER CORPORATION 2002-09-05 — — US disclosed
EP-1191955-A1 BIOLOGIC REPLACEMENT FOR FIBRIN CLOT FOR INTRA-ARTICULAR USE THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2002-04-03 — — EP disclosed
WO-2000078370-A1 BIOLOGIC REPLACEMENT FOR FIBRIN CLOT FOR INTRA-ARTICULAR USE THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2000-12-28 — — WO disclosed
US-RE34986-E Tanning agent formulation for manufacture of semifinished leather products SCHILL & SEILACHER GMBH & CO. (DE) 1995-07-04 — — US disclosed
US-5011499-A Improved mold resistance; free of metal salts and formaldehyde SCHILL & SEILACHER GMBH & CO. (DE) 1991-04-30 — — US disclosed
US-4810624-A COPOLYMERS OF SULFONATES AND PRIMARY AMINES E. I. DUPONT DE NEMOURS AND COMPANY (US) 1989-03-07 — — US disclosed
US-4693969-A POLYMER OF BIOACTIVE SUBSTANCE-SPECIFIC ANTIBODY: ENZYME CONJUGATE CORNELL RESEARCH FOUNDATION, INC. (US) 1987-09-15 — — US disclosed
US-4668748-A STYRENESULFONATES, UNSATURATED AMINES, PHOTOGRAPHIC FILMS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-05-26 — — US disclosed
Send feedback